A Promising Future for Marine Drugs and Natural Products

Natural products, although a valuable and precious resource, also come with their fair share of challenges in a variety of aspects. As mentioned before, one of the major issues concerning the use of natural products are the difficulties associated with obtaining sufficient amounts of material pure enough for discovery and development activities. If a compound is derived from a plant growing only in small quantities or remote locations or a marine organisms residing in great depth or difficult to access regions, Ayurveda medicine  re-supply becomes a problem. The threat of losing potentially valuable natural sources of pharmacologically active ingredients is constantly increasing due to the threat of extinction by deforestation of large landmasses and environmental pollution in remote areas as well as global warming. It is estimated that about 70% of the supply of herbal raw material other homeopathic medicine in India comes from the wild. To meet the increasing demand for raw material, to conserve wild resources, and to reduce the potential variability in the active ingredient content in medicinal plants from different collection areas, it is important to implement more controlled cultivation programs to ensure quality and to protect resources 

Natural product screening remains one of the most useful avenues for bioactive discovery. In the past decades, studies on MNP have been focused mainly on macroorganisms, i.e., sponges, corals and other marine invertebrates, although significant developments have been made in the microorganisms area. However, despite the large number of NCEs isolated from marine organisms, many of them with pronounced biological activity, the great majority does not surpass the pharmaceutical pre-clinical trials and only a very few have been marketed as pharmaceutical products. Besides the usual drawbacks in any drug discovery process, the industrial development of many promising MNP was hampered by additional difficulties such as sustainable source and issues related to structural complexity and scale up. Nevertheless, the global marine pharmaceutical pipeline remains very active and includes, at the moment, eight Food and Drug Administration (FDA) or European Medicines Agency (EMEA) approved drugs and several compounds in different phases of the clinical pipeline.

  • Improved bioavailability
  • Relevant mechanisms of action
  • Most potent inhibitors
  • Less unwanted side effects
  • Potential drug targets encoded by human genome
  • Innovations in marine natural products research

Related Conference of A Promising Future for Marine Drugs and Natural Products

April 20-21, 2018

4th International Conference on Antibiotics: R&D, B2B

Las Vegas, Nevada, USA
April 26-27, 2018

11th European Biosimilars Congress

Rome, Italy
May 07-09, 2018

15th Annual European Pharma Congress

Frankfurt, Germany
June 04-05, 2018 | Baltimore, Maryland, USA

5th International Conference on Natural Products & Marine Drugs

June 20-22, 2018

7th World Congress on Mass Spectrometry

Rome, Italy
July 18-19, 2018

12th Global
Pharmacovigilance & Clinical Trials Summit

Sydney, Australia
July 18-20, 2018

15th Asia-Pacific Pharma Congress

Melbourne, Australia
Jul 30-Aug 01, 2018

10th World Congress on Pharmacology

Barcelona, Spain
August 15-17, 2018

14th World Congress on Pharmacology and Drug Safety

Stockholm, Sweden
September 13-14, 2018

8th World Congress on Chromatography

Prague, Czech Republic
September 14-15, 2018

Annual Neurochemistry and Neuropharmacology Congress

Richmond, USA
September 17-18, 2018

15th International Conference on Pharmaceutical Formulations & Drug Delivery

| Philadelphia, Pennsylvania, USA
September 17-18, 2018

Drug formulation Congress 2018

Singapore
September 20-22, 2018

17th Annual Congress on Pharmaceutics & Novel Drug Delivery Systems

Prague, Czech Republic
September 24-26, 2018

7th International Conference on Clinical Trials

Chicago, USA
(10 Plenary Forums - 1 Event)
September 24-25, 2018

Pharmacoepidemiology 2018

Dubai, UAE
September 24-25, 2018

12th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Chicago, Illinois, USA
August 24-25, 2018

7th Global Advances in Mass Spectrometry

Singapore
October 24-25, 2018

13th International Conference on Biopharma and Biotherapeutics

Boston, Massachusetts, USA
November 05-06, 2018

18th Annual Pharmaceutical Chemical Analysis Congress

Madrid, Spain
November 15-16, 2018

9th Global Experts Meeting on Neuropharmacology

Frankfurt, Germany

A Promising Future for Marine Drugs and Natural Products Conference Speakers

Recommended Sessions

Related Journals

Are you interested in